Canada Markets close in 5 hrs 7 mins

DiaMedica Therapeutics Inc. (DMAC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.43+0.13 (+2.45%)
As of 10:43AM EDT. Market open.
Currency in USD

Valuation Measures

Market Cap (intraday) 576.78M
Enterprise Value 389.54M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)6.81
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-8.51

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 353.18%
S&P500 52-Week Change 3N/A
52 Week High 38.80
52 Week Low 31.70
50-Day Moving Average 36.28
200-Day Moving Average 34.70

Share Statistics

Avg Vol (3 month) 392k
Avg Vol (10 day) 3174.29k
Shares Outstanding 514.14M
Float 14.14M
% Held by Insiders 19.04%
% Held by Institutions 120.26%
Shares Short (Jul. 30, 2020) 44.93k
Short Ratio (Jul. 30, 2020) 40.15
Short % of Float (Jul. 30, 2020) 40.04%
Short % of Shares Outstanding (Jul. 30, 2020) 40.03%
Shares Short (prior month Jun. 29, 2020) 412.68k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Nov. 14, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Jun. 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-51.93%
Return on Equity (ttm)-85.55%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -10.52M
Net Income Avi to Common (ttm)-9.83M
Diluted EPS (ttm)-0.77
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)11.8M
Total Cash Per Share (mrq)0.63
Total Debt (mrq)148k
Total Debt/Equity (mrq)1.31
Current Ratio (mrq)10.19
Book Value Per Share (mrq)0.80

Cash Flow Statement

Operating Cash Flow (ttm)-6.92M
Levered Free Cash Flow (ttm)-4.43M